An international research team including researchers from Augsburg University Medicine has made significant progress in the risk assessment and treatment of extracranial malign rhabdoid tumors. Recently published in the journal Clinical Cancer Research, the study, “Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors,” shows how clinical and molecular factors can influence disease progression and contribute to improvements in individual treatment.
This article was originally published on MedicalXpress.com
